CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis

Abstract A hallmark of glioma cells, particularly glioblastoma multiforme (GBM) cells, is their resistance to apoptosis. Accumulating evidences has demonstrated that CARD16, a caspase recruitment domain (CARD) only protein, enhances both anti-apoptotic and tumorigenic properties. Nevertheless, there...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruoheng Xuan, Tianyu Hu, Lingshan Cai, Beichuan Zhao, Erqiao Han, Zhibo Xia
Format: Article
Language:English
Published: Nature Publishing Group 2024-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07196-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061912138579968
author Ruoheng Xuan
Tianyu Hu
Lingshan Cai
Beichuan Zhao
Erqiao Han
Zhibo Xia
author_facet Ruoheng Xuan
Tianyu Hu
Lingshan Cai
Beichuan Zhao
Erqiao Han
Zhibo Xia
author_sort Ruoheng Xuan
collection DOAJ
description Abstract A hallmark of glioma cells, particularly glioblastoma multiforme (GBM) cells, is their resistance to apoptosis. Accumulating evidences has demonstrated that CARD16, a caspase recruitment domain (CARD) only protein, enhances both anti-apoptotic and tumorigenic properties. Nevertheless, there is a limited understanding of the expression and functional role of CARD16 in glioma. This study seeks to investigate, through in silico analysis and clinical specimens, the role of CARD16 as a potential tumor promoter in glioma. Functional assays and molecular studies revealed that CARD16 promotes tumorigenesis and suppresses apoptosis in glioma cells. Moreover, knockdown of CARD16 enhances the expression of the FOXO1/TRAIL axis in GBM cells. Additionally, FOXO1 downregulation in CARD16 knockdown GBM cells restores proliferation and reduces apoptosis. Further investigation demonstrated that elevated P21 expression inhibits CDK2-mediated FOXO1 phosphorylation and ubiquitination in CARD16-knockdown GBM cells. Collectively, these findings suggest that CARD16 is a tumor-promoting molecular in glioma via downregulating FOXO1/TRAIL axis, and suppressing TRAIL-induced apoptosis. The CARD16 gene presents significant potential for prognostic prediction and advances in innovative apoptotic therapeutics.
format Article
id doaj-art-d15be9c8079c41c4b3cd79ff0733af80
institution DOAJ
issn 2041-4889
language English
publishDate 2024-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-d15be9c8079c41c4b3cd79ff0733af802025-08-20T02:50:04ZengNature Publishing GroupCell Death and Disease2041-48892024-11-01151111410.1038/s41419-024-07196-2CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axisRuoheng Xuan0Tianyu Hu1Lingshan Cai2Beichuan Zhao3Erqiao Han4Zhibo Xia5Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen UniversityAbstract A hallmark of glioma cells, particularly glioblastoma multiforme (GBM) cells, is their resistance to apoptosis. Accumulating evidences has demonstrated that CARD16, a caspase recruitment domain (CARD) only protein, enhances both anti-apoptotic and tumorigenic properties. Nevertheless, there is a limited understanding of the expression and functional role of CARD16 in glioma. This study seeks to investigate, through in silico analysis and clinical specimens, the role of CARD16 as a potential tumor promoter in glioma. Functional assays and molecular studies revealed that CARD16 promotes tumorigenesis and suppresses apoptosis in glioma cells. Moreover, knockdown of CARD16 enhances the expression of the FOXO1/TRAIL axis in GBM cells. Additionally, FOXO1 downregulation in CARD16 knockdown GBM cells restores proliferation and reduces apoptosis. Further investigation demonstrated that elevated P21 expression inhibits CDK2-mediated FOXO1 phosphorylation and ubiquitination in CARD16-knockdown GBM cells. Collectively, these findings suggest that CARD16 is a tumor-promoting molecular in glioma via downregulating FOXO1/TRAIL axis, and suppressing TRAIL-induced apoptosis. The CARD16 gene presents significant potential for prognostic prediction and advances in innovative apoptotic therapeutics.https://doi.org/10.1038/s41419-024-07196-2
spellingShingle Ruoheng Xuan
Tianyu Hu
Lingshan Cai
Beichuan Zhao
Erqiao Han
Zhibo Xia
CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
Cell Death and Disease
title CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
title_full CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
title_fullStr CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
title_full_unstemmed CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
title_short CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis
title_sort card16 restores tumorigenesis and restraints apoptosis in glioma cells via foxo1 trail axis
url https://doi.org/10.1038/s41419-024-07196-2
work_keys_str_mv AT ruohengxuan card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis
AT tianyuhu card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis
AT lingshancai card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis
AT beichuanzhao card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis
AT erqiaohan card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis
AT zhiboxia card16restorestumorigenesisandrestraintsapoptosisingliomacellsviafoxo1trailaxis